Aaron Kent

Consultant Radiation Oncologist - Alfred Health. Special interest: GU / Brachytherapy. Aspiring runner | enthusiastic Zwifter. West Coast member. Views = my own

[ESTRO @ESTRO_RT]

Just published in @TheLancet Oncology: Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma — an ESTRO study endorsed by EAU.
👉 Read the summary: https://t.co/rRjIs6EBnE
@Uroweb

[Shankar Siva @_ShankarSiva]

"The Right Tool for the Job: The Knife, the SABR, or Fire and Ice?" - this month's @IJROBP Gray Zone asks what to do with the risky small renal mass.... @MichaelStaehler and I respond here; https://t.co/pQqkwaZ20A
#radonc

[Peter Mac Radiation Oncology @PeterMacRadOnc]

"Prostate cancer." An outstanding seminar published in @TheLancet! Congratulations to our own Prof Scott Williams for leading this eminent collaboration with @Shahneen3, @mrsprostate, @EdChiongUROonc, Himisha Beltran @DanaFarber & Robert Bristow @MCRCnews. https://t.co/gIVDHEDREb

[Katie Brown @brownbeansprout]

#Lungcancer diagnosis and treatment should be “stigma-free” @lungevity @DrewMoghanaki #lcsm https://t.co/zKuH5oL7Ab